New Flu Vaccine Approved by U.S Food and Drug Administration
October 6, 2006 — JesseOctober 2006 (Medialink) — GlaxoSmithKline [NYSE: GSK] announced that the US Food and Drug Administration (FDA) has approved FluLaval(TM) [Influenza Virus Vaccine] for the active immunization of adults 18 years and older against influenza disease, commonly known as the flu, caused by influenza virus types A and B contained in the vaccine. The approval of FluLaval is another major step towards increasing the influenza vaccine supply in the United States, following the introduction of GSK’s …
Read more:
New Flu Vaccine Approved by U.S Food and Drug Administration